From: New challenges for microRNAs in acute pancreatitis: progress and treatment
miRNA | Target | Functional role | In vitro/in vivo | References |
---|---|---|---|---|
miR-9 | FGF10/NF-κB | Inhibits expression of the inflammatory factors IL-1β, IL-6 and TNF-α, as well as the apoptosis factors Bax and cl-caspase 3/9 | In vitro | [35] |
miR-668, miR-3594-3p, miR-24-3p, miR-483-5p, miR-3541 | TRAF6-TAB2-TAK1-NIK/IKK-NF-κB pathway | Activates macrophages and promotes IL-1β, IL-6 and TNF-α production | In vitro | [43] |
miR-216a | Akt and TGF-β Pathway | Promotes TNF-α and IL-6 production | Both | [36] |
miR-30a-5p | HTRA/TGF-β1 | Inhibits the production of trypsin, amylase and the inflammatory factors TNF-α, IL-6 and IL-1β | Both | [47] |
miR-155 | SOCS1 | Promotes Th17 cell production and IL-6, IL-13 and TNF-α expression | Both | [51] |
miR-361-5p | NFIA and Hes1 | Promotes Th17 cells to secrete IL-17A | Both | [52] |
miR-29a/b1 | – | Promotes infiltration of neutrophils and macrophages and release of IL-6, IL-10 and TGFβ1 | In vivo | [53] |
miR-155 | TAB2 | Promote the production of Beclin-1 and LC3 II levels and worsens the degree of autophagy damage | In vivo | [58] |
miR-92b-3p | TRAF3/MKK3-p38 | Increases levels of Beclin-1, LC3 II and autophagosome formation | In vitro | [59] |
miR-21 | Caspase 8 | Upregulation of RIP1 and RIP3 expression promotes necrosome formation | In vivo | [63] |
miR-19b | – | Promotes necrosis of pancreatic acinar cells | In vivo | [64] |
miR-15a | MAP2K4/JKN | Inhibits the production of IL-1, TNF and IL-6 and reduces pancreatic tissue necrosis | Both | [65] |